Essential Premium

Greenlight Delivers Gains in a Losing Month for Stocks

David Einhorn’s fund bucked February’s volatility with strength from its largest long positions, outperforming a market weighed down by broad declines.

Allocators Prefer the ‘Fluffy Airy’ Words of Private Equity to the Hard Math of Hedge Funds

But Verdad founder Dan Rasmussen says that a reckoning is coming.

Sponsored

Self-Storage: Structural Strength Meets Cyclical Opportunity

Hedge Funds Capture Big Early Gains in Select Biotech IPOs — With One Notable Exception

Major funds, including Suvretta, RA Capital, and Viking, took sizable stakes ahead of these offerings, positioning themselves to benefit from the sector’s strongest debuts.

Related Content

Greenlight Builds Momentum After Summer Losses

Stephen Taub

‘AI Supercycle Is Here to Stay’: Light Street Posts Strong January Returns as It Revamps Tech Strategy

Stephen Taub

Coatue Launches VC Fund

Stephen Taub

1270 Avenue of the Americas, Suite 1100

New York, NY 10020

 

© Institutional Investor, LLC. All material subject to strictly enforced copyright laws. Please read our Terms and Conditions and Privacy Policy before using the site. Institutional Investor is part of Delinian.

 

| Unsubscribe

LinkedIn
X (Twitter)
Bluesky
Instagram